This week marks the official launch of Orthocell’s new GMP certified bio-manufacturing facility at the Company headquarters in Perth.
The launch of this new facility is a major milestone for Orthocell. Following a landmark $23.1m global exclusive marketing and distribution deal with BioHorizons last year, the team embarked on a program of capital works to scale its manufacturing capabilities ten-fold, to meet international demand for its novel dental bone regeneration product, Striate+â„¢.
A number of special guests were in attendance, including the Hon. Stephen Dawson MLC. Minister for Emergency Services; Innovation and the Digital Economy; Medical Research; Volunteering – together with long standing clinical and commercial contributors, and selected patients who have personally benefited from the Company’s regenerative medicine therapies.
